Bhagiradha Chemicals & Industries Limited sees a credit rating action

The subsidiary’s rated bank facilities total Rs 600 Crores (INR 6,000 million), carrying IND BBB+/Stable/IND A2+ ratings. ^[1]

The facility schedule does distinguish the mix:

• Term loans: INR 1,600 million, or Rs 160 Crores — Axis Bank INR 750 million, ICICI Bank INR 600 million and RBL Bank INR 250 million.
• Working-capital limits: INR 850 million, or Rs 85 Crores — fund-based and non-fund-based limits.
• Proposed bank-loan facilities: INR 3,550 million, or Rs 355 Crores, without further classification in the table. ^[2]

The rating rationale links the company’s borrowings to the ongoing debt-funded capex programme and separately notes working-capital utilisation; however, it does not explicitly state that every term-loan tranche is exclusively a capex loan. It indicates that the term-loan component is consistent with capex funding, while the working-capital limits support the business’s working-capital-intensive operations. ^{[3] [4]}

The available rating reference does not establish that Bhagiradha Chemicals has provided a corporate guarantee or letter of comfort for the subsidiary facilities. It only refers to the company’s ratings information and does not state that such support was issued ^[5]. A definitive conclusion would require the specific credit-rating rationale covering those facilities.

Consolidated leverage is nevertheless materially higher than standalone leverage:

• FY26 consolidated gross debt-to-equity was 0.33x, versus 0.12x standalone ^{[6] [7]}.
• Consolidated debt was Rs 231.06 Crores, compared with Rs 90.23 Crores standalone; the difference of approximately Rs 140.83 Crores is derived from these reported figures and indicates that subsidiary borrowings are being captured in consolidation ^{[8] [9]}.
• Consolidated equity was Rs 698.32 Crores, versus Rs 723.56 Crores standalone ^{[10] [11]}.

Implication: the 0.33x ratio already reflects the accounting consolidation of subsidiary debt; a corporate guarantee or letter of comfort would not normally be added again as debt and therefore would not mechanically increase the reported consolidated debt-to-equity ratio. It would, however, create additional contingent/support exposure for the parent and could matter to the rating agency’s assessment of group obligations. The key distinction is whether the support is merely disclosed as a guarantee/comfort instrument or whether it has been invoked and converted into an actual liability.

Bheema Fine Chemicals remains a small contributor to Bhagiradha Chemicals’ reported scale, but its recent operating profile appears to be improving. In Q4 FY26, the subsidiary’s implied revenue contribution was approximately Rs 8.94 Crores, or 5.65% of consolidated revenue, while its implied EBIT margin was about 4.81%, below the parent’s standalone margin and the consolidated margin.

Notes: † Derived as consolidated revenue less standalone revenue, divided by consolidated revenue. ‡ Derived as consolidated EBIT less standalone EBIT, divided by implied subsidiary revenue. The difference method can include consolidation or inter-company adjustments; the company does not provide a directly reported subsidiary income statement in the cited material.

• On a TTM FY26 basis, the implied subsidiary contribution was approximately Rs 14.73 Crores, or 2.75% of consolidated revenue, based on consolidated revenue of Rs 535.95 Crores versus standalone revenue of Rs 521.22 Crores ^{[18] [19]}. The implied subsidiary EBIT was negative on this basis: consolidated TTM EBIT was Rs 38.58 Crores versus standalone TTM EBIT of Rs 41.56 Crores ^{[20] [21]}. This suggests that earlier-period start-up or ramp-up costs diluted group profitability, although Q4 appears less adverse.
• The parent’s consolidated Q4 operating margin was only 0.2 percentage points below its standalone margin—7.5% versus 7.7% ^{[17] [16]}. Thus, the subsidiary is not yet large enough to change the group margin structure materially, but its historical losses have weakened consolidated profitability relative to the parent standalone business.

Operational dependencies identified by the rating report

Yes. The CARE rationale identifies financial and operational linkages as the reason for assessing Bhagiradha on a consolidated basis. It specifically states that:

• Bheema was a 100% subsidiary and was in the project stage at the time of the assessment.
• Its proposed products were expected to be mostly similar to those manufactured by Bhagiradha.
• Both entities were managed by common management.
• Bheema’s expansion involved debt-funded capex, with earlier environmental and consent approvals causing project delay and cost overrun ^[22].

The report therefore points to dependence through common management, overlapping product capability and parent–subsidiary financial linkage. It does not, in the cited rationale, identify a specific inter-company supply agreement, guaranteed revenue arrangement, captive customer relationship or formal cash-support commitment.